These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Bridgford JL; Xie SC; Cobbold SA; Pasaje CFA; Herrmann S; Yang T; Gillett DL; Dick LR; Ralph SA; Dogovski C; Spillman NJ; Tilley L Nat Commun; 2018 Sep; 9(1):3801. PubMed ID: 30228310 [TBL] [Abstract][Full Text] [Related]
51. A human microdose study of the antimalarial drug GSK3191607 in healthy volunteers. Okour M; Derimanov G; Barnett R; Fernandez E; Ferrer S; Gresham S; Hossain M; Gamo FJ; Koh G; Pereira A; Rolfe K; Wong D; Young G; Rami H; Haselden J Br J Clin Pharmacol; 2018 Mar; 84(3):482-489. PubMed ID: 29168205 [TBL] [Abstract][Full Text] [Related]
52. Machine learning for artemisinin resistance in malaria treatment across Zhang H; Guo J; Li H; Guan Y iScience; 2022 Mar; 25(3):103910. PubMed ID: 35243261 [TBL] [Abstract][Full Text] [Related]
53. Nutrient Limitation Mimics Artemisinin Tolerance in Malaria. Brown AC; Warthan MD; Aryal A; Liu S; Guler JL mBio; 2023 Jun; 14(3):e0070523. PubMed ID: 37097173 [TBL] [Abstract][Full Text] [Related]
54. A Click Chemistry-Based Proteomic Approach Reveals that 1,2,4-Trioxolane and Artemisinin Antimalarials Share a Common Protein Alkylation Profile. Ismail HM; Barton VE; Panchana M; Charoensutthivarakul S; Biagini GA; Ward SA; O'Neill PM Angew Chem Weinheim Bergstr Ger; 2016 May; 128(22):6511-6515. PubMed ID: 27397940 [TBL] [Abstract][Full Text] [Related]
55. Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin. Phompradit P; Chaijaroenkul W; Na-Bangchang K Parasitol Res; 2017 Dec; 116(12):3331-3339. PubMed ID: 29127525 [TBL] [Abstract][Full Text] [Related]
56. Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of mount Cameroon: cross-sectional study. Apinjoh TO; Mugri RN; Miotto O; Chi HF; Tata RB; Anchang-Kimbi JK; Fon EM; Tangoh DA; Nyingchu RV; Jacob C; Amato R; Djimde A; Kwiatkowski D; Achidi EA; Amambua-Ngwa A Infect Dis Poverty; 2017 Nov; 6(1):136. PubMed ID: 29110722 [TBL] [Abstract][Full Text] [Related]
57. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Landier J; Kajeechiwa L; Thwin MM; Parker DM; Chaumeau V; Wiladphaingern J; Imwong M; Miotto O; Patumrat K; Duanguppama J; Cerqueira D; Malleret B; Rénia L; Nosten S; von Seidlein L; Ling C; Proux S; Corbel V; Simpson JA; Dondorp AM; White NJ; Nosten FH Wellcome Open Res; 2017; 2():81. PubMed ID: 29062913 [No Abstract] [Full Text] [Related]
58. Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations. Sugiarto SR; Davis TME; Salman S Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1115-1133. PubMed ID: 29027504 [TBL] [Abstract][Full Text] [Related]
59. Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates. Chirawurah JD; Ansah F; Nyarko PB; Duodu S; Aniweh Y; Awandare GA Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):399-406. PubMed ID: 29128848 [TBL] [Abstract][Full Text] [Related]
60. An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria. Saralamba S; Simpson JA; Choosri N; White L; Pan-Ngum W; Dondorp AM; White NJ J Antimicrob Chemother; 2023 Sep; 78(9):2192-2202. PubMed ID: 37473441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]